724 organization(s) found
Curenetics
Curenetics is an AI driven precision oncology company transforming how cancer treatments are discovered, developed, and selected. Our Cure-IO platform aggregates and analyses complex patient data including genomics, medical imaging, and clinical records from hospitals and laboratories to build advanced AI models that integrate multiple biomarkers. This multimodal approach delivers unprecedented predictive accuracy, helping identify those patients most likely to benefit from specific therapies.
CYBERNA
Cyberna is developing innovative in vitro diagnostic (IVD) tests for early detection of cancer through a simple blood drop
Cyrus Therapeutics
Cyrus Therapeutics is a leading biotechnology company that is discovering and developing innovative medicines to conquer chronic or life-threatening diseases with high unmet needs. It is estimated that about 3,000 targets are �undruggable� (about 16% of a total of 20,000 human proteins). We are committed to making our mission��drugging the undruggable targets��possible with small molecule drugs as well as new chemical modalities such as targeted protein degraders.
Daiichi-Sankyo
We share a passion for innovation, as well as compassion for the patients around the world who are in need of our medicines.
Dana-Farber Cancer Institute
Since its founding in 1947, Dana-Farber Cancer Institute in Boston, Massachusetts has been committed to providing adults and children with cancer with the best treatment available today while developing tomorrow's cures through cutting-edge research.
Debiopharm
Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to develop tomorrow's standard of care to cure cancer & infectious diseases and improve patient quality of life. Our main activities include drug development, drug manufacturing and digital health investment.
Dispatch Bio
We’re on a mission to help create a world where all cancer patients can be cured.
Doherty Institute (Peter Doherty Institute for Infection and Immunity)
The Doherty Institute aims to prevent, treat and cure infectious diseases through research, public health and education.
Dong-A ST
Dong-A ST focuses on the development and sale of specialized pharmaceuticals (ETC) and is dedicated to the philosophy of "Our company's social contribution is in new drug development." With state-of-the-art research facilities such as the Yongin Research Center established in 1977 and the completion of the Songdo Research Center in 2021, Dong-A ST has been striving for innovative global new drug development with excellent research and development capabilities.
EACR
The European Association for Cancer Research (EACR), a registered charity, is a global community for those working & studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.” We facilitate communication and collaboration within the cancer research community, provide a variety of support and funding opportunities, and organise highly rated webinars, scientific conferences and an annual congress.
EANO (European Association of Neuro-Oncology)
EANO is Europe’s multidisciplinary Neuro-Oncology organisation representing all medical and scientific disciplines involved in the prevention, diagnosis and treatment of tumours of the central nervous system (CNS). EANO is dedicated to promote advances in Neuro-Oncology through innovative research and concerted education and training. It enhances collaboration between all relevant disciplines - Neuro-Oncology, Neurosurgery, Neuropathology, Neuroradiology, and Radiation Oncology as well as Nursing - and aims at bridging science, knowledge and practice gaps in the management of CNS malignancies.
EANS (European Association of Neurosurgical Societies)
We at the EANS are a fast-growing, independent association, both of European neurosurgical societies and of individual neurosurgeons all over the world. Our aim is to enable our members to enhance the care they deliver to their patients by facilitating the exchange of scientific information at the highest level. In pursuit of this goal, we arrange a wide range of meetings, symposia and educational courses, including the European Congress of Neurosurgery and the highly regarded European Training Courses in Neurosurgery. Other key activities in line with our mission include the provision of a comprehensive online library of neurosurgical material via the EANS Academy, several awards and prizes and fellowship and observership programmes. Through the European Board of Neurological Surgery (EBNS) we run the Fellow of the EBNS exam (parts I and II).
EBC Council (European Breast Cancer Council)
The platform for breast cancer specialists and patient advocates
ECC (Egyptian Cancer Center)
In Arabic: "المركز الأول في مصر لتشخيص وعلاج جميع أنواع الأورام في الجسم بأستخدام التكنولوجيا و التقنيات الحديثة. المركز المصري للأورام هو المركز الوحيد في مصر الذي يقدم رعاية شاملة لمرضي السرطان . تغطي كافة المراحل من التشخيص حتي الشفاء يضم المركز كافة التخصصات اللازمة لعلاج الأورام مما يضمن أعلي نسب شفاء في جميع أنواع الأورام."
ECCNI (End Cervical Cancer Nigeria Initiative)
Promotes cervical cancer prevention, screening, and vaccination programs.
ECS (Egyptian Cancer Society)
The Egyptian Cancer society (ECS) was founded in 1991 as a branch of Egyptian medical association. It is an independent non-profit association and dose not issue licenses. Our Vision: To be a leading force in the fight against cancer in Egypt and the region, transforming cancer care through innovation, education, and advocacy while ensuring equitable access to world-class treatment and empowering healthcare professionals to improve patient outcomes Our Mission: Upgrading the medical knowledge among oncologists in Egypt and the Arab countries, through constant meetings and discussions. Advancement in cancer prevention, diagnosis, and therapy. Awareness of Cancer-related problems. Persistent and continues activities to the community via outreach programs. Collaboration with other regional and international cancer societies.
EHA
The European Hematology Association (EHA) is the largest hematology community in Europe. A not-for-profit, membership-driven association based in the Netherlands. Effectively advocating for our members and the wider community at the highest level. Organizer of the annual EHA Congress, Europe’s largest hematology event.
EHESP (Ecole des hautes études en santé publique)
The EHESP is a public establishment with a dual role of education and research into public health and social welfare. It encourages synergy between the disparate cultures of public health and management. Four missions are conferred to EHESP by law: · to provide training for persons who have to exercise leadership, management, inspection or control functions in the health, social or medico-social fields; · to provide a network of higher education in public health; · to contribute to public health research activities; · to develop international relations, in particular through exchanges with institutions providing comparable teaching. The EHESP stands for the values of defending fundamental collective values around public service ethics, general interest, respect, openness and cooperation, continual improvement, and social and environmental responsibility.
Eikon Therapeutics
Eikon is a late-stage clinical biopharmaceutical company dedicated to inventing and developing breakthrough therapeutics through the purposeful integration of science and engineering.
EKCC - Addis Ababa (Else Kröner Center for Cancer Care)
The Else Kröner Center for Cancer Care (EKCC) project in Ethiopia is a comprehensive initiative aimed at enhancing and decentralizing cancer care in the country to reduce morbidity and mortality rates associated with breast and cervical cancer. With a budget of 2.5 million euros, the project lasts from February 2020 to January 2026. The project is being implemented by the Addis Ababa University School of Public Health in collaboration with the medical Faculty of Medicine at Martin Luther University Halle-Wittenberg.
Ellipses Pharma
Ellipses Pharma develops new treatments for cancer that address unmet clinical need. We are focused exclusively on the development of innovative cancer medicines.
Elpiscience Biopharmaceuticals
Elpiscience has pioneered a globally leading pipeline of groundbreaking immunotherapies, focusing on critical targets to address the significant unmet clinical needs in oncology and autoimmune diseases.